Dupilumab in the treatment of dystrophic epidermolysis bullosa: off-label use in a pediatric patient.

Authors :: Xará J
Relvas M
Figueiredo C
Calvão J
Batista M
Ramos L
Source :: International journal of dermatology [Int J Dermatol] 2023 Dec; Vol. 62 (12), pp. e617-e618. Date of Electronic Publication: 2023 Aug 25.
Publication Year :: 2023

Subjects :: Humans
Child
Off-Label Use
Skin
Antibodies, Monoclonal, Humanized therapeutic use
Epidermolysis Bullosa Dystrophica complications
Epidermolysis Bullosa Dystrophica drug therapy
Epidermolysis Bullosa

Full Text Access

Tools